The activity of GR205171, a potent non-peptide tachykinin NK1 receptor antagonist, in the trigeminovascular system

Regulatory Peptides

Volumn 68, Issue 1, 1997, Pages 23-29

  Polley, J S ^a   Gaskin, P J ^a   Perren, M J ^a   Connor, H E ^a   Ward, P ^a   Beattie, D T ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cranial vasculature; Migraine; Trigeminal nucleus caudalis

Indexed keywords

ANTIMIGRAINE AGENT; SUBSTANCE P METHYL ESTER; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VOFOPITANT;

ANIMAL EXPERIMENT; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; GENE EXPRESSION; GUINEA PIG; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIGRAINE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; RABBIT; RAT; VASCULAR RESISTANCE;

ANIMALS; BLOOD PROTEINS; CAROTID ARTERIES; FEMALE; GUINEA PIGS; MALE; MOLECULAR STRUCTURE; PIPERIDINES; PROTO-ONCOGENE PROTEINS C-FOS; RABBITS; RATS; RECEPTORS, NEUROKININ-1; TETRAZOLES; TRIGEMINAL NERVE;

ANIMALIA; CAVIA; CAVIA PORCELLUS; ORYCTOLAGUS CUNICULUS; SUS SCROFA;

EID: 0031568237     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(96)00137-1     Document Type: Article

References (25)

1. Moskowitz, M.A., Buzzi, M.G., Sakas, D.E. and Linnik, M.D., Pain mechanisms underlying vascular headaches, Rev. Neurol., 145 (1989) 181-193.
2. Edvinsson, L., Rosendal-Helgesen, S. and Uddman, R., Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater, Cell Tissue Res., 234 (1983) 1-7.
3. Goadsby, P.J., Edvinsson, L. and Ekman, R., Release of vasoactive peptides in the extracerebral circulation of man and the cat during activation of the trigeminovascular system, Ann. Neurol., 23 (1988) 193-196.
4. Nicolodi, M. and Del Bianco, E., Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache, Cephalalgia, 10 (1990) 39-50.
5. Beattie, D.T., Stubbs, C.M., Connor, H.E. and Feniuk, W., Neurokinin-induced changes in pial artery diameter in the anaesthetized guinea-pig, Br. J. Pharmacol., 108 (1993) 146-149.
6. Edvinsson, L., McCulloch, J. and Uddman, R., Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ, J. Physiol., 318 (1981) 251-258.
7. Markowitz, S., Saito, K. and Moskowitz, M.A., Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain, J. Neurosci., 7 (1987) 4129-4136.
8. 1 antagonist CP-99,994 on plasma protein extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats, Neuropharmacology, 34 (1995) 255-261.
9. 1) receptor, Science, 251 (1991) 435-439.
10. McLean, S., Ganong, A., Seymour, P.A., Snider, R.M., Desai, M.C., Rosen, T., Bryce, D.K., Longo, K.P., Reynolds, L.S., Robinson, G., Schmidt, A.W., Siok, C. and Heym, J., Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor, J. Pharmacol. Exp. Ther., 267 (1993) 472-479.
11. 1 receptor antagonist, Eur. J. Pharmacol., 250 (1993) 403-413.
12. Garret, C., Carruette, A., Fardin, V., Moussaoui, S., Peyronel, J.-F., Blanchard, J.-C. and Laduron, P.M., Pharmacological properties of a potent and selective nonpeptide substance P antagonist, Proc. Natl. Acad. Sci. USA, 88 (1991) 10208-10212.
13. 1 receptor antagonist, Br. J. Pharmacol., 116 (1995) 3149-3157.
14. Gitter, B.D., Bruns, R.F., Howbert, J.J., Waters, D.C., Threlkeld, P.G., Cox, L.M., Nixon, J.A., Lobb, K.L., Mason, N.R., Stengel, P.W., Cockerham, S.L., Silbaugh, S.A., Gehlert, D.R., Schober, D.A., Iyengar, S., Calligaro, D.O., Regoli, D. and Hipskind, P.A., Pharmacological characterization of LY303870: a novel, potent and selective nonpeptide substance P (neurokinin-1) receptor antagonist, J. Pharmacol. Exp. Ther., 275 (1995) 737-744.
15. 1 receptor, and potent broad-spectrum anti-emetic activity, Regul. Pept., 65 (1996) 45-53.
16. Buzzi, M.G. and Moskowitz, M.A., The anti-migraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma protein extravasation from blood vessels in dura mater, Br. J. Pharmacol., 99 (1990) 202-206.
17. 1 and CGRP receptor-mediated dilatation of the carotid arterial bed in the anaesthetised rabbit, Neuropeptides, 30 (1996) 141-148.
18. 1 receptor antagonist, RP 67580, Eur. J. Pharmacol., 238 (1993) 421-424.
19. Shepheard, S.L., Williamson, D.J., Hill, R.G. and Hargreaves, R.J., The non-peptide neurokinin-1 receptor antagonist, RP67580, blocks neurogenic plasma extravasation in the dura mater of rats, Br. J. Pharmacol., 108 (1993) 11-12.
20. 1 receptors mediate plasma protein extravasation in guinea-pig dura, Eur. J. Pharmacol., 236 (1993) 319-321.
21. Salt, T.E., Crozier, C.S. and Hill, R.G., The effects of capsaicin pre-treatment on the responses of single neurones to sensory stimuli in the trigeminal nucleus caudalis of the rat: evidence against a role for substance P as the neurotransmitter serving thermal nociception, Neuroscience, 7 (1982) 1141-1148.
22. Yonehara, N., Sawada, T., Matsura, H. and Inoki, R., Influence of electro-acupuncture on the release of substance P and the potential evoked by tooth pulp stimulation in the trigeminal nucleus caudalis of the rabbit, Neurosci. Lett., 142 (1992) 53-56.
23. Cutrer, F.M., Moussaoui, S., Garret, C. and Moskowitz, M.A., The non-peptide neurokinin-1 antagonist, RPR100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation, Neuroscience, 64 (1995) 741-750.
24. Goadsby, P.J., Edvinsson, L. and Ekman, R., Vasoactive peptide release in extracerebral circulation of humans during migraine headache, Ann. Neurol., 28 (1990) 183-187.
25. Olesen, J., Thomsen, L.L. and Iversen, H.K., Nitric oxide is a key molecule in migraine and other vascular headaches, Trends Pharmacol. Sci., 15 (1994) 149-153.